Leptin/ObR are present in a broad range of brain tumors, with the level of expression associated with the degree of malignancy, raising the possibility that phenotyping of peripheral circulating leptin/ObR may be a useful strategy for predicting tumor grade. This evidence concerns the gene LEPR and brain neoplasm.